Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.

Banavathy S KruthikaHarsha SugurKanuri NandakiArivazhagan ArimappamaganKondaiah PaturuVani Santosh

Published in: Journal of clinical pathology (2019)

We show MYL9 as a novel biomarker, variably expressed in GBM. The association of high MYL9 expression with poor prognosis in newly diagnosed GBM patients and increased expression in recurrent GBM is indicative of its role in conferring tumour aggressiveness.

Keyphrases

poor prognosis
newly diagnosed
long non coding rna
end stage renal disease
ejection fraction
prognostic factors
peritoneal dialysis